James F Howard

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 29

Top Venues

Muscle & nerve

Annals of clinical and translational neurology

Journal of neurology

Therapeutic advances in neurological disorders

University of North Carolina at Chapel Hill School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of North Carolina at Chapel Hill School of Medicine Jul 01 1979

United States

Distinguished Professor :: Neurology

Publications

James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve 69 (5) (2024)
James F Howard, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma, John Hinton, Yessar Hussain, Raul Juntas-Morales, Henry J Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Richard J Nowak, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D Weiss, Małgorzata Zajda, Jos Bloemers, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W Duda, Mark Vanderkelen, M Isabel Leite, null null
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study. Therapeutic advances in neurological disorders 17 (2024)
James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve 69 (5) (2024)
James F Howard, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma, John Hinton, Yessar Hussain, Raul Juntas-Morales, Henry J Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Richard J Nowak, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D Weiss, Małgorzata Zajda, Jos Bloemers, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W Duda, Mark Vanderkelen, M Isabel Leite, null null
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study. Therapeutic advances in neurological disorders 17 (2024)
Thomas H Brannagan, Andrew J Klink, Srikanth Muppidi, Anju Parthan, S Chloe Sader, Alexandrina Balanean, Ajeet Gajra, Richard J Nowak, James F Howard, null null
United States clinical practice experience with eculizumab in myasthenia gravis: symptoms, function, and immunosuppressant therapy use. Journal of neurology (2024)
James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve (2024)
James F Howard, Tuan Vu, Renato Mantegazza, Hani Kushlaf, Shigeaki Suzuki, Heinz Wiendl, Kathleen N Beasley, Serena Liao, Andreas Meisel, null null
Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study. Muscle & nerve 69 (5) (2024)
James F Howard, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge, Channa Hewamadduma, John Hinton, Yessar Hussain, Raul Juntas-Morales, Henry J Kaminski, Angelina Maniaol, Renato Mantegazza, Masayuki Masuda, Richard J Nowak, Kumaraswamy Sivakumar, Marek Śmiłowski, Kimiaki Utsugisawa, Tuan Vu, Michael D Weiss, Małgorzata Zajda, Jos Bloemers, Babak Boroojerdi, Melissa Brock, Guillemette de la Borderie, Petra W Duda, Mark Vanderkelen, M Isabel Leite, null null
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study. Therapeutic advances in neurological disorders 17 (2024)
Vera Bril, James F Howard, Chafic Karam, Jan L De Bleecker, Hiroyuki Murai, Kimiaki Utsugisawa, Peter Ulrichts, Edward Brauer, Sihui Zhao, Renato Mantegazza, Tuan Vu, null null
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study. European journal of neurology (2023)
Gianvito Masi, Minh C Pham, Tabitha Karatz, Sangwook Oh, Aimee S Payne, Richard J Nowak, James F Howard, Jeffrey T Guptill, Vern C Juel, Kevin C O'Connor
Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravis. Annals of clinical and translational neurology (2023)
Gianvito Masi, Minh C Pham, Tabitha Karatz, Sangwook Oh, Aimee S Payne, Richard J Nowak, James F Howard, Jeffrey T Guptill, Vern C Juel, Kevin C O'Connor
Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravis. Annals of clinical and translational neurology (2023)
Andreas Meisel, Djillali Annane, Tuan Vu, Renato Mantegazza, Masahisa Katsuno, Rasha Aguzzi, Glen Frick, Laura Gault, James F Howard, null null
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension. Journal of neurology (2023)
Andreas Meisel, Djillali Annane, Tuan Vu, Renato Mantegazza, Masahisa Katsuno, Rasha Aguzzi, Glen Frick, Laura Gault, James F Howard, null null
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension. Journal of neurology (2023)
Yan Wang, Lily Guo, Xihui Yin, Ethan C McCarthy, Mandy I Cheng, Aline T Hoang, Ho-Chung Chen, Anushi Y Patel, Denise Allard Trout, Erin Xu, Natalie Yakobian, Willy Hugo, James F Howard, Katherine M Sheu, Alexander Hoffmann, Melissa G Lechner, Maureen A Su
Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity. Proceedings of the National Academy of Sciences of the United States of America 119 (4) (2022)
James F Howard, Chafic Karam, Marcus Yountz, Fanny L O'Brien, Tahseen Mozaffar, null null
Long-term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses. Annals of clinical and translational neurology 8 (7) (2021)
Renato Mantegazza, Fanny L O'Brien, Marcus Yountz, James F Howard, null null
Consistent improvement with eculizumab across muscle groups in myasthenia gravis. Annals of clinical and translational neurology 7 (8) (2020)
Renato Mantegazza, Gil I Wolfe, Srikanth Muppidi, Heinz Wiendl, Kenji P Fujita, Fanny L O'Brien, Heather D E Booth, James F Howard, null null
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension. Neurology 96 (4) (2020)
Jeffrey T Guptill, Richard Barfield, Cliburn Chan, Melissa A Russo, Doug Emmett, Shruti M Raja, Janice M Massey, Vern C Juel, Lisa D Hobson-Webb, Karissa L Gable, Natalia Gonzalez, Alex Hammett, James F Howard, Manisha Chopra, Henry J Kaminski, Zaeem A Siddiqi, Mattingly Migdal, John S Yi
Reduced plasmablast frequency is associated with seronegative myasthenia gravis. Muscle & nerve 63 (4) (2020)
Michael H Rivner, Brandy M Quarles, Jin-Xiu Pan, Zheng Yu, James F Howard, Andrea Corse, Mazen M Dimachkie, Carlayne Jackson, Tuan Vu, George Small, Robert P Lisak, Jerry Belsh, Ikjae Lee, Richard J Nowak, Vanessa Baute, Stephen Scelsa, J Americo Fernandes, Zachary Simmons, Andrea Swenson, Richard Barohn, R Bhavaraju Sanka, Clifton Gooch, Eroboghene Ubogu, James Caress, Mamatha Pasnoor, Hongyan Xu, Lin Mei
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study. Muscle & nerve 62 (3) (2020)
Daniel G Areson, William G Filer, Matthew G Harris, James F Howard, Lee T Shuping, Rebecca Traub
Accuracy of the Scratch Collapse Test for Carpal Tunnel Syndrome in Comparison With Electrodiagnostic Studies. Hand (New York, N.Y.) (2020)
James F Howard, Vera Bril, Ted M Burns, Renato Mantegazza, Malgorzata Bilinska, Andrzej Szczudlik, Said Beydoun, Francisco Javier Rodriguez De Rivera Garrido, Fredrik Piehl, Mariarosa Rottoli, Philip Van Damme, Tuan Vu, Amelia Evoli, Miriam Freimer, Tahseen Mozaffar, E Sally Ward, Torsten Dreier, Peter Ulrichts, Katrien Verschueren, Antonio Guglietta, Hans de Haard, Nicolas Leupin, Jan J G M Verschuuren, null null
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis. Neurology 92 (23) (2019)
Henning Andersen, Renato Mantegazza, Jing Jing Wang, Fanny O'Brien, Kaushik Patra, James F Howard, null null
Eculizumab improves fatigue in refractory generalized myasthenia gravis. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 28 (8) (2019)
Katherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, Ted M Burns, Carolina Barnett-Tapia, Nicholas J Silvestri, James F Howard, Amy Visser, Brian A Crum, Richard Nowak, Rachel Beekman, Aditya Kumar, Katherine Ruzhansky, I-Hweii Amy Chen, Michael T Pulley, Shannon M Laboy, Melissa A Fellman, Diantha B Howard, Noah Allan Kolb, Shane M Greene, Mamatha Pasnoor, Mazen M Dimachkie, Richard J Barohn, Michael K Hehir
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis. Muscle & nerve 59 (4) (2019)
Shruti M Raja, James F Howard, Vern C Juel, Janice M Massey, Manisha Chopra, Jeffrey T Guptill
Clinical outcome measures following plasma exchange for MG exacerbation. Annals of clinical and translational neurology 6 (10) (2019)
Srikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J Barohn, Isabel Illa, Saiju Jacob, John Vissing, Ted M Burns, John T Kissel, Richard J Nowak, Henning Andersen, Carlos Casasnovas, Jan L de Bleecker, Tuan H Vu, Renato Mantegazza, Fanny L O'Brien, Jing Jing Wang, Kenji P Fujita, James F Howard, null null
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis. Muscle & nerve 60 (1) (2019)
Collin-Jamal Smith, Denise E Allard, Yan Wang, James F Howard, Stephanie A Montgomery, Maureen A Su
IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration. Journal of immunology (Baltimore, Md. : 1950) 200 (5) (2018)
John Vissing, Fanny O'Brien, Jing Jing Wang, James F Howard
Correlation between myasthenia gravis-activities of daily living (MG-ADL) and quantitative myasthenia gravis (QMG) assessments of anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis in the phase 3 regain study. Muscle & nerve 58 (2) (2018)
James F Howard, Miriam Freimer, Fanny O'Brien, Jing Jing Wang, Stephen R Collins, John T Kissel, null null
QMG and MG-ADL correlations: Study of eculizumab treatment of myasthenia gravis. Muscle & nerve 56 (2) (2017)
Vern C Juel, Donald B Sanders, Lisa D Hobson-Webb, Janice M Massey, Jeffrey T Guptill, Fanny O'Brien, Jing Jing Wang, James F Howard
Marked clinical and jitter improvement after eculizumab in refractory myasthenia. Muscle & nerve 56 (3) (2017)

James F Howard.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

James F Howard